FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286742019> ?p ?o ?g. }

• W4286742019 endingPage "2377" @default.
• W4286742019 startingPage "2366" @default.
• W4286742019 abstract "Abstract HDIT101 is a first‐in‐class humanized monoclonal antibody recognizing a conserved epitope in glycoprotein B, a target present on the surface of herpes simplex virus 1 (HSV‐1) and HSV‐2 particles as well as on virus‐infected cells. This was a first‐in‐human, single‐center, double‐blind, placebo‐controlled trial in 24 healthy volunteers, randomized 3:1 (placebo:active) in each of the six dose levels with escalating doses up to 12,150 mg HDIT101. HDIT101 was administered intravenously, to study safety, pharmacokinetics (PKs), and immunogenicity. HDIT101 was well‐tolerated in all recipients and no serious or severe adverse events, no infusion‐related reactions, and no events suggestive of dose limiting off‐target toxicity occurred. The mean serum exposure (area under the curve from zero to infinity [AUC 0‐∞ ]) of HDIT101 showed a linear increase from 4340 h*μg/ml at a dose of 50 mg to 1,122,247 h*μg/ml at a dose of 12,150 mg. No immunogenic effects following HDIT101 exposure were observed at any of the applied doses. HDIT101 demonstrated the expected PK properties of a monoclonal antibody was well‐tolerated, and could be safely administered even at excessively high doses that may be required for treatment of patients with septical HSV spread." @default.
• W4286742019 created "2022-07-23" @default.
• W4286742019 creator A5008211601 @default.
• W4286742019 creator A5008819108 @default.
• W4286742019 creator A5012434727 @default.
• W4286742019 creator A5018159424 @default.
• W4286742019 creator A5022664570 @default.
• W4286742019 creator A5030416479 @default.
• W4286742019 creator A5044089291 @default.
• W4286742019 creator A5044600024 @default.
• W4286742019 creator A5045680407 @default.
• W4286742019 creator A5047821467 @default.
• W4286742019 creator A5068825967 @default.
• W4286742019 creator A5075947367 @default.
• W4286742019 creator A5082719401 @default.
• W4286742019 creator A5087189932 @default.
• W4286742019 creator A5090147251 @default.
• W4286742019 creator A5090671577 @default.
• W4286742019 date "2022-07-23" @default.
• W4286742019 modified "2023-09-26" @default.
• W4286742019 title "First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody <scp>HDIT101</scp> in healthy volunteers" @default.
• W4286742019 cites W1869955658 @default.
• W4286742019 cites W2052633355 @default.
• W4286742019 cites W2059050919 @default.
• W4286742019 cites W2071699268 @default.
• W4286742019 cites W2103385926 @default.
• W4286742019 cites W2116819372 @default.
• W4286742019 cites W2134397718 @default.
• W4286742019 cites W2137186878 @default.
• W4286742019 cites W2140811217 @default.
• W4286742019 cites W2143012846 @default.
• W4286742019 cites W2165752902 @default.
• W4286742019 cites W2261829991 @default.
• W4286742019 cites W2606721249 @default.
• W4286742019 cites W2794420673 @default.
• W4286742019 cites W2910600665 @default.
• W4286742019 cites W3022275668 @default.
• W4286742019 cites W3207492005 @default.
• W4286742019 cites W4286742019 @default.
• W4286742019 doi "https://doi.org/10.1111/cts.13365" @default.
• W4286742019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35869929" @default.
• W4286742019 hasPublicationYear "2022" @default.
• W4286742019 type Work @default.
• W4286742019 citedByCount "2" @default.
• W4286742019 countsByYear W42867420192022 @default.
• W4286742019 countsByYear W42867420192023 @default.
• W4286742019 crossrefType "journal-article" @default.
• W4286742019 hasAuthorship W4286742019A5008211601 @default.
• W4286742019 hasAuthorship W4286742019A5008819108 @default.
• W4286742019 hasAuthorship W4286742019A5012434727 @default.
• W4286742019 hasAuthorship W4286742019A5018159424 @default.
• W4286742019 hasAuthorship W4286742019A5022664570 @default.
• W4286742019 hasAuthorship W4286742019A5030416479 @default.
• W4286742019 hasAuthorship W4286742019A5044089291 @default.
• W4286742019 hasAuthorship W4286742019A5044600024 @default.
• W4286742019 hasAuthorship W4286742019A5045680407 @default.
• W4286742019 hasAuthorship W4286742019A5047821467 @default.
• W4286742019 hasAuthorship W4286742019A5068825967 @default.
• W4286742019 hasAuthorship W4286742019A5075947367 @default.
• W4286742019 hasAuthorship W4286742019A5082719401 @default.
• W4286742019 hasAuthorship W4286742019A5087189932 @default.
• W4286742019 hasAuthorship W4286742019A5090147251 @default.
• W4286742019 hasAuthorship W4286742019A5090671577 @default.
• W4286742019 hasBestOaLocation W42867420192 @default.
• W4286742019 hasConcept C111113717 @default.
• W4286742019 hasConcept C112705442 @default.
• W4286742019 hasConcept C126322002 @default.
• W4286742019 hasConcept C142724271 @default.
• W4286742019 hasConcept C159047783 @default.
• W4286742019 hasConcept C159654299 @default.
• W4286742019 hasConcept C195616568 @default.
• W4286742019 hasConcept C197934379 @default.
• W4286742019 hasConcept C203014093 @default.
• W4286742019 hasConcept C204787440 @default.
• W4286742019 hasConcept C2522874641 @default.
• W4286742019 hasConcept C27081682 @default.
• W4286742019 hasConcept C2780868878 @default.
• W4286742019 hasConcept C2781196997 @default.
• W4286742019 hasConcept C29730261 @default.
• W4286742019 hasConcept C542903549 @default.
• W4286742019 hasConcept C71924100 @default.
• W4286742019 hasConcept C76318530 @default.
• W4286742019 hasConcept C98274493 @default.
• W4286742019 hasConceptScore W4286742019C111113717 @default.
• W4286742019 hasConceptScore W4286742019C112705442 @default.
• W4286742019 hasConceptScore W4286742019C126322002 @default.
• W4286742019 hasConceptScore W4286742019C142724271 @default.
• W4286742019 hasConceptScore W4286742019C159047783 @default.
• W4286742019 hasConceptScore W4286742019C159654299 @default.
• W4286742019 hasConceptScore W4286742019C195616568 @default.
• W4286742019 hasConceptScore W4286742019C197934379 @default.
• W4286742019 hasConceptScore W4286742019C203014093 @default.
• W4286742019 hasConceptScore W4286742019C204787440 @default.
• W4286742019 hasConceptScore W4286742019C2522874641 @default.
• W4286742019 hasConceptScore W4286742019C27081682 @default.
• W4286742019 hasConceptScore W4286742019C2780868878 @default.
• W4286742019 hasConceptScore W4286742019C2781196997 @default.
• W4286742019 hasConceptScore W4286742019C29730261 @default.

• next